Humacyte Reports Q1 2026 Results: Full Earnings Call Transcript
Corroborated by 2 sources from 2 publishers
globalbusiness14h ago
TL;DR
Humacyte earnings beat by $0.03, revenue fell short of estimates Humacyte (NASDAQ:HUMA) released first-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and financial data.